DIANTHUS THERAPEUTICS INC (DNTH) Stock Analyst Earnings Estimates
NASDAQ:DNTH - Nasdaq - US2528281080 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 2.826M | 5.656M 100.14% | 3.785M -33.08% | 3.665M -3.17% | 51.221M | 190.02M 270.98% | 416.94M 119.42% | 648.73M 55.59% | 869.62M 34.05% | |||
| EBITDA YoY % growth | -72.67M 5.28% | -78.97M -8.67% | -48.107M 39.08% | -79.001M -64.22% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -74.69M 5.10% | -80.9M -8.31% | -48.174M 40.45% | -104.683M -117.30% | -146.999M -40.42% | -176.805M -20.28% | -176.822M | -55.945M 68.36% | 143.97M 357.34% | 306.83M 113.12% | 436.31M 42.20% | |
| Operating Margin | N/A | N/A | -1,704.67% | -1,850.84% | -3,883.73% | -4,824.13% | -345.21% | -29.44% | 34.53% | 47.30% | 50.17% | |
| EPS YoY % growth | -1.31 24.71% | -20.64 -1,475.57% | -12.97 37.16% | -2.61 79.85% | -3.52 -34.74% | -3.90 -10.64% | -3.27 | -3.52 -7.48% | -1.85 47.54% | 0.52 128.18% | 3.43 558.82% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.87 -22.24% | -0.91 -69.29% | -0.96 -88.25% | -0.97 -31.29% | -0.92 -5.62% |
| Revenue Q2Q % growth | 876.894K 91.88% | 957.637K 9.57% | 972.203K -47.82% | 972.203K -55.24% | 972.203K 10.87% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -33.127M -155.69% | -33.198M -86.05% | -32.757M -47.53% | -35.05M -17.22% | -37.847M -14.25% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.74 80.42% | -0.61 | -0.13 | -22.05% |
| Q2 2024 Q2Q % growth | -0.51 36.25% | -0.56 | 0.05 | 8.35% |
| Q1 2024 Q2Q % growth | -0.54 92.97% | -0.45 | -0.09 | -20.87% |
| Q4 2023 Q2Q % growth | -0.71 86.95% | -1.03 | 0.32 | 31.08% |
| Q3 2023 Q2Q % growth | -3.78 12.50% | -0.57 | -3.21 | -561.76% |
| Q2 2023 Q2Q % growth | -0.80 82.76% | -3.10 | 2.30 | 74.20% |
| Q1 2023 Q2Q % growth | -7.68 -23.08% | -6.69 | -0.99 | -14.78% |
| Q4 2022 Q2Q % growth | -5.44 -1,548.48% | -4.41 | -1.03 | -23.46% |
| Q3 2022 Q2Q % growth | -4.32 -1,340.00% | -4.90 | 0.58 | 11.76% |
| Q2 2022 Q2Q % growth | -4.64 -1,350.00% | -5.39 | 0.75 | 13.84% |
| Q1 2022 Q2Q % growth | -6.24 -1,633.33% | -5.11 | -1.13 | -22.21% |
| Q4 2021 Q2Q % growth | -0.33 13.16% | -0.33 | 0.00 | -0.58% |
| Q3 2021 Q2Q % growth | -0.30 18.92% | -0.33 | 0.03 | 10.41% |
| Q2 2021 Q2Q % growth | -0.32 33.33% | -0.39 | 0.07 | 17.00% |
| Q1 2021 Q2Q % growth | -0.36 29.41% | -0.41 | 0.05 | 12.20% |
| Q4 2020 Q2Q % growth | -0.38 35.59% | -0.42 | 0.04 | 10.32% |
| Q3 2020 Q2Q % growth | -0.37 31.48% | -0.46 | 0.09 | 19.17% |
| Q2 2020 Q2Q % growth | -0.48 | -0.55 | 0.07 | 12.57% |
| Q1 2020 Q2Q % growth | -0.51 -15.91% | -0.61 | 0.10 | 15.79% |
| Q4 2019 Q2Q % growth | -0.59 | -0.60 | 0.01 | 2.35% |
| Q3 2019 Q2Q % growth | -0.54 | -0.55 | 0.01 | 2.36% |
| Q2 2019 Q2Q % growth | -0.48 | -0.54 | 0.06 | 10.70% |
| Q1 2019 Q2Q % growth | -0.44 | -0.59 | 0.15 | 24.85% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 2.172M 135.06% | 661.47K | 1.511M | 228.36% |
| Q2 2024 Q2Q % growth | 1.863M | 329.205K | 1.534M | 465.91% |
| Q1 2024 Q2Q % growth | 874K | 473.535K | 400.465K | 84.57% |
| Q4 2023 Q2Q % growth | 457K | 312.12K | 144.88K | 46.42% |
| Q3 2023 Q2Q % growth | 924K | 255K | 669K | 262.35% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -3.52% | 0% | 0.67% |
| Revenue | 0% | 6.16% | 0% | 1.98% |